Eutectic-based self-emulsifying drug delivery system for enhanced oral delivery of risperidone.
Saved in:
| Title: | Eutectic-based self-emulsifying drug delivery system for enhanced oral delivery of risperidone. |
|---|---|
| Authors: | Rifai, Alaa1 (AUTHOR), Alkhawaja, Bayan1 (AUTHOR), Al-Akayleh, Faisal1 (AUTHOR) falakayleh@uop.edu.jo, Al-Remawi, Mayyas1 (AUTHOR), Nasereddin, Jehad2 (AUTHOR), Abdel Rahim, Safwan3 (AUTHOR), Woodman, Tim4 (AUTHOR), Ali Agha, Ahmed Saad Abdulbari1 (AUTHOR) |
| Source: | Journal of Dispersion Science & Technology. 2026, Vol. 47 Issue 8, p1548-1559. 12p. |
| Subject Terms: | *Drug delivery systems, *Bioavailability, *Drug solubility, *Oral drug administration, *Risperidone, *Excipients |
| Abstract: | Implementing therapeutic deep eutectic systems (THDESs) in various drug delivery systems (DDSs) has expanded enormously. THDESs offer eco-friendly alternatives to conventional organic solvents, featuring adaptable and simple preparation methods with high-yield products. Previously, the solubility of risperidone (RISP) was immensely enhanced by forming a hydrophobic THDES of RISP with capric acid (CA). To build upon the previous findings and utilize the hydrophobic properties of THDES, a self-emulsifying drug delivery system (SEDDS) was developed. A stable SEDDS formulation was successfully developed using the THDES as the nonpolar phase, a nonionic surfactant, Tween 20, and a co-surfactant, PEG 400. By employing a pseudo-ternary phase diagram, the ideal ratio of Tween 20 to PEG 400 was determined to be 3:1. The developed SEDDS demonstrated robust stability in thermal stability tests, dispersity evaluations, and dilution tests, exhibiting no instances of phase separation or precipitation. Gratifyingly, the in vitro dissolution of RISP through the developed SEDDS showed a higher release by 3-fold after 5 min and achieved 90% release within 2 hours. More interestingly, the plasma profile of RISP and the SEDDS were compared in rats, which revealed an improved drug bioavailability, as indicated by the attained higher AUC0–∞ (3907.06 versus 3426.28 h µg/ml) and a significantly higher Cmax (68.97 versus 50.35 µg/ml) with the SEDDS formulation when compared to RISP. [ABSTRACT FROM AUTHOR] |
| Database: | Energy & Power Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: enr DbLabel: Energy & Power Source An: 194165982 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Eutectic-based self-emulsifying drug delivery system for enhanced oral delivery of risperidone. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Rifai%2C+Alaa%22">Rifai, Alaa</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alkhawaja%2C+Bayan%22">Alkhawaja, Bayan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Al-Akayleh%2C+Faisal%22">Al-Akayleh, Faisal</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> falakayleh@uop.edu.jo</i><br /><searchLink fieldCode="AR" term="%22Al-Remawi%2C+Mayyas%22">Al-Remawi, Mayyas</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nasereddin%2C+Jehad%22">Nasereddin, Jehad</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abdel+Rahim%2C+Safwan%22">Abdel Rahim, Safwan</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Woodman%2C+Tim%22">Woodman, Tim</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ali+Agha%2C+Ahmed+Saad+Abdulbari%22">Ali Agha, Ahmed Saad Abdulbari</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Journal+of+Dispersion+Science+%26+Technology%22">Journal of Dispersion Science & Technology</searchLink>. 2026, Vol. 47 Issue 8, p1548-1559. 12p. – Name: Subject Label: Subject Terms Group: Su Data: *<searchLink fieldCode="DE" term="%22Drug+delivery+systems%22">Drug delivery systems</searchLink><br />*<searchLink fieldCode="DE" term="%22Bioavailability%22">Bioavailability</searchLink><br />*<searchLink fieldCode="DE" term="%22Drug+solubility%22">Drug solubility</searchLink><br />*<searchLink fieldCode="DE" term="%22Oral+drug+administration%22">Oral drug administration</searchLink><br />*<searchLink fieldCode="DE" term="%22Risperidone%22">Risperidone</searchLink><br />*<searchLink fieldCode="DE" term="%22Excipients%22">Excipients</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Implementing therapeutic deep eutectic systems (THDESs) in various drug delivery systems (DDSs) has expanded enormously. THDESs offer eco-friendly alternatives to conventional organic solvents, featuring adaptable and simple preparation methods with high-yield products. Previously, the solubility of risperidone (RISP) was immensely enhanced by forming a hydrophobic THDES of RISP with capric acid (CA). To build upon the previous findings and utilize the hydrophobic properties of THDES, a self-emulsifying drug delivery system (SEDDS) was developed. A stable SEDDS formulation was successfully developed using the THDES as the nonpolar phase, a nonionic surfactant, Tween 20, and a co-surfactant, PEG 400. By employing a pseudo-ternary phase diagram, the ideal ratio of Tween 20 to PEG 400 was determined to be 3:1. The developed SEDDS demonstrated robust stability in thermal stability tests, dispersity evaluations, and dilution tests, exhibiting no instances of phase separation or precipitation. Gratifyingly, the in vitro dissolution of RISP through the developed SEDDS showed a higher release by 3-fold after 5 min and achieved 90% release within 2 hours. More interestingly, the plasma profile of RISP and the SEDDS were compared in rats, which revealed an improved drug bioavailability, as indicated by the attained higher AUC0–∞ (3907.06 versus 3426.28 h µg/ml) and a significantly higher Cmax (68.97 versus 50.35 µg/ml) with the SEDDS formulation when compared to RISP. [ABSTRACT FROM AUTHOR] |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=enr&AN=194165982 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/01932691.2024.2448748 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 1548 Subjects: – SubjectFull: Drug delivery systems Type: general – SubjectFull: Bioavailability Type: general – SubjectFull: Drug solubility Type: general – SubjectFull: Oral drug administration Type: general – SubjectFull: Risperidone Type: general – SubjectFull: Excipients Type: general Titles: – TitleFull: Eutectic-based self-emulsifying drug delivery system for enhanced oral delivery of risperidone. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rifai, Alaa – PersonEntity: Name: NameFull: Alkhawaja, Bayan – PersonEntity: Name: NameFull: Al-Akayleh, Faisal – PersonEntity: Name: NameFull: Al-Remawi, Mayyas – PersonEntity: Name: NameFull: Nasereddin, Jehad – PersonEntity: Name: NameFull: Abdel Rahim, Safwan – PersonEntity: Name: NameFull: Woodman, Tim – PersonEntity: Name: NameFull: Ali Agha, Ahmed Saad Abdulbari IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 01932691 Numbering: – Type: volume Value: 47 – Type: issue Value: 8 Titles: – TitleFull: Journal of Dispersion Science & Technology Type: main |
| ResultId | 1 |